Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia

AIMS/HYPOTHESIS: Heterozygous glucokinase (GCK) mutations cause mild, fasting hyperglycaemia from birth. Although patients are usually asymptomatic and have glycaemia within target ranges, some are put on pharmacological treatment. We aimed to investigate how many patients are on pharmacological tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Stride, Amanda, Shields, Beverley, Gill-Carey, Olivia, Chakera, Ali J., Colclough, Kevin, Ellard, Sian, Hattersley, Andrew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855531/
https://www.ncbi.nlm.nih.gov/pubmed/24092492
http://dx.doi.org/10.1007/s00125-013-3075-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855531/
https://www.ncbi.nlm.nih.gov/pubmed/24092492
http://dx.doi.org/10.1007/s00125-013-3075-x

Ejemplares similares